SSC 2026
Sepsis Guidelines
SSC 2026 — Sections
Clinical Domains
🏠Overview
🔍Screening & Early Mgmt1–15
💊Infection & Antimicrobials16–41
❤️Hemodynamic Management42–64
🫀Respiratory Support65–78
⚗️Adjunctive Therapies79–99
🤝Goals of Care100–107
🔄Transitions of Care108–123
🌿Long-term Recovery124–129
Quick Filters
🔍
Search
Type to search all 129 recommendations
📋
SSC 2026 Sepsis Guidelines
Surviving Sepsis Campaign • Critical Care Medicine • April 2026 • 129 Statements
🔍15
Screening & Early Mgmt
Statements 1–15
💊26
Infection & Antimicrobials
Statements 16–41
❤️23
Hemodynamic Management
Statements 42–64
🫀14
Respiratory Support
Statements 65–78
⚗️21
Adjunctive Therapies
Statements 79–99
🤝8
Goals of Care
Statements 100–107
🔄16
Transitions of Care
Statements 108–123
🌿6
Long-term Recovery
Statements 124–129
⇧ Key Changes from SSC 2021
⇧ Beta-lactam infusion → STRONG (BLING III) NEW: MAP 60–65 for age ≥65 yrs NEW: Peripheral vasopressors first NEW: MDR risk stratification NEW: HFNC preferred over NIV NEW: Awake proning NEW: Against antipyretics for outcomes NEW: SDD in low-AMR ICUs NEW: Against Vitamin D treatment NEW: Against beta-blockers in shock
🎙️ Color Guide
Strong Recommendation
"we recommend"
Conditional Recommendation
"we suggest"
Strong Against
"we recommend against"
Conditional Against
"we suggest against"
Good Practice Statement
GPS
Insufficient Evidence
no recommendation

● Green dot = New in 2026 • Tap any card to expand

🔍
Screening & Early Management
Statements 1–15 • Tap cards to expand
💊
Infection & Antimicrobials
Statements 16–41 • Includes pharmacy-critical recommendations
❤️
Hemodynamic Management
Statements 42–64 • Vasopressor ladder & fluid tables included
🫀
Respiratory Support
Statements 65–78
⚗️
Adjunctive Therapies
Statements 79–99 • Pharmacy-key recommendations included
🤝
Goals of Care
Statements 100–107
🔄
Transitions of Care
Statements 108–123
🌿
Long-term Recovery
Statements 124–129